Clinical Trials Logo

Fibromatosis Desmoid clinical trials

View clinical trials related to Fibromatosis Desmoid.

Filter by:
  • None
  • Page 1

NCT ID: NCT03966742 Completed - Desmoid Clinical Trials

Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis

Start date: October 11, 2018
Phase: Phase 2
Study type: Interventional

In this study Drug-eluting microbeads (DEB) loaded with Doxorubicin will be delivered into the target Desmoid Fibromatoses (DF) tissue via selective arterial embolization by angiographic technique. The objective of the study is to demonstrate the safety and efficacy of this treatment.